In honor of the occasion, Tien Lee, M.D., CEO & Founder, rings the Closing Bell. Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered ...
It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.